CHICAGO, June 26,
2024 /PRNewswire/ -- The urinalysis market, valued at
USD 4.3 billion in 2024 and projected
to grow to USD 6.8 billion by 2029
with a CAGR of 9.6%, is driven by several key factors. These
include the rising prevalence of chronic and lifestyle diseases,
technological advancements in point-of-care (PoC) testing products,
and growing patient awareness. Moreover, the market faces
challenges such as high capital investments and a shortage of
skilled laboratory technicians. Opportunities lie in advancements
in urine analyzers, particularly automated systems, and overcoming
regulatory hurdles in the changing landscape of in vitro
diagnostics (IVD). Major players like Siemens Healthineers, F.
Hoffmann-La Roche Ltd., Cardinal Health, Abbott, and Danaher
dominate the market with their extensive product portfolios and
global presence.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
Browse in-depth TOC on "Urinalysis
Market"
483 - Tables
49 - Figures
390 -
Pages
Product Segmentation in the Urinalysis Market: Consumables
and Instruments
The urinalysis market is segmented into consumables and
instruments. Consumables, including pregnancy & fertility kits,
dipsticks, reagents, and disposables, dominated the market in 2023.
These products are essential for routine testing in hospitals,
clinics, and labs, especially for chronic disease monitoring.
Test Types Driving Market Growth: Biochemical, Sediment, and
Pregnancy Tests
The urinalysis market is categorized by test types such as
biochemical, sediment, and pregnancy & fertility tests. In
2023, pregnancy & fertility tests held the largest market share
due to increasing awareness and adoption of home testing options,
particularly in developing regions.
Application Insights: Disease Screening Leads Market
Demand
Disease screening, including for conditions like UTIs and kidney
ailments, accounted for the predominant share of the urinalysis
market in 2023. The necessity for regular monitoring of chronic
conditions fuels the demand for urinalysis, supporting this
segment's growth.
Regional Analysis and Growth Projections: Asia Pacific Shows
Highest Potential
The urinalysis market is segmented across North America, Europe, Asia
Pacific, Latin America, the
Middle East & Africa, and GCC countries. Asia Pacific is anticipated to exhibit the
highest CAGR, driven by governmental initiatives to enhance
healthcare accessibility and fund research in disease
diagnostics.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
Market Leaders Driving Innovation and Expansion
Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd.
(Switzerland), and Cardinal Health
(US) emerge as key players in the urinalysis market. In 2023,
Siemens Healthineers AG led the market with its extensive product
portfolio and strategic investments in research and development.
The company's partnerships and expansions reinforce its market
dominance, enhancing technological integration across its
offerings.
Roche's Dominance in Biochemical Urinalysis
F. Hoffmann-La Roche Ltd. (Switzerland) maintains a significant market
share in biochemical urinalysis through its diverse portfolio of
urine analyzers and test strips. The company's focus on innovation
and substantial investments in R&D underscores its leadership
position, bolstered by a robust global distribution network
facilitating widespread product accessibility.
Cardinal Health's Strategic Initiatives for Market
Expansion
Cardinal Health (US) secured a prominent position in the
urinalysis market by optimizing its global supply chain and
expanding self-manufacturing capabilities. Notably, the
establishment of new distribution centers in Central Ohio in April
2023 exemplifies the company's commitment to enhancing
operational efficiency and supporting its US Medical Products and
Distribution segments.
Sysmex Corporation Launches Advanced Urine Analyzer
In September 2022, Sysmex
Corporation introduced the UF-1500 Fully Automated Urine Particle
Analyzer, enhancing diagnostic capabilities in urine sediment
testing. This innovation underscores Sysmex's commitment to
advancing automated diagnostic solutions for accurate and efficient
urine analysis.
Quidel Corporation Expands Diagnostic Portfolio through
Acquisition
In May 2022, Quidel Corporation
(US) expanded its diagnostic portfolio with the acquisition of
Ortho Clinical Diagnostics (US). This strategic move bolsters
Quidel's expertise in cellular-based virology assays and molecular
diagnostic systems, reinforcing its leadership in the global
diagnostics market.
Siemens Healthineers and Unilabs Forge Strategic
Partnership
In February 2023, Siemens
Healthineers partnered with Unilabs in a multi-year agreement to
modernize Unilabs' healthcare infrastructure. This collaboration
aims to enhance operational efficiency and customer service across
Unilabs' extensive testing network, leveraging Siemens
Healthineers' innovative diagnostic solutions.
Cardinal Health Expands Distribution Network for Enhanced
Market Reach
Cardinal Health (US) announced in April
2023 the opening of two new distribution centers in
Central Ohio. These facilities
support Cardinal Health's Medical segment and At-home Solutions
businesses, optimizing its global supply chain to meet growing
demand and strengthen market leadership.
Siemens Healthineers Innovates with New Erlangen Innovation
Center
In July 2023, Siemens Healthineers
inaugurated the Erlangen Innovation Center in Germany, focusing on open innovation
initiatives. The center fosters collaborations with clinical,
academic partners, and startups to drive advancements in healthcare
technologies and solutions.
For more information, inquire now! Inquire Now
Related Reports:
Point of Care Diagnostics Market
Clinical Chemistry Analyzers Market
Life Science Instrumentation Market
In Vitro Diagnostics Market
Stoma Care Market
Get access to the latest updates on Urinalysis Companies
and Urinalysis Market Size
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/urinalysis-market-worth-usd-6-8-billion-by-2029-growth-drivers-key-players-and-trends--marketsandmarkets-302182981.html
SOURCE MarketsandMarkets